H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 7.4% of adults in Madison have diagnosed diabetes — 4.6 points below the U.S. 12% figure. Census population 269,840. Wisconsin Medicare wound biologics: National Government Services (NGS) (J6). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Madison clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Madison storefront.
Orthobiologic Treatments for Your Practice in Madison, WI for clinics & physicians. Premium orthobiologic… Compliance support & pricing — contact Hawk Medical.
Adult obesity in Madison is 32.7% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. CDC PLACES (2023, crude) estimates 7.4% of adults in Madison have diagnosed diabetes — 4.6 points below the U.S. 12% figure. Wisconsin is outside CDC’s core Diabetes Belt list; use the PLACES city rate anyway. Hawk Medical is the distributor for orthobiologic treatments, not a walk-in clinic.
National Orthobiologic Treatments for Your Practice notes (how the product actually works)America’s Health Rankings (BRFSS 2024) only publishes state diabetes as a range nationally (Colorado 8.4% to West Virginia 18.4%). For Madison we use CDC PLACES instead of interpolating a fake city rate from that range. CDC PLACES (2023, crude) estimates 7.4% of adults in Madison have diagnosed diabetes — 4.6 points below the U.S. 12% figure.
We are not going to invent a Madison warehouse or a five-star local review. What you get is orthobiologic treatments from FDA-registered sources, lot paperwork, and someone who has run the same SOPs in clinic — Joe Bradley. The local numbers on this page are CDC PLACES and CMS J6, not marketing adjectives.
CDC PLACES (2023, crude prevalence) estimates 7.4% of adults — 4.6 points below the U.S. 12% figure. Obesity is 32.7%; arthritis is 17%. That is place-level BRFSS modeling, not a clinic census and not a Madison trial.
The 96.5% figure is a product-level clinical experience statistic published on our wound-care materials — not a city-specific trial. Your outcomes will depend on patient selection, offloading, and follow-up.
No. National Government Services (NGS) writes coverage. We train staff on documentation patterns those articles already require (wound measurements, conservative care, units). That is support, not a coverage guarantee.
No. Hawk Medical does not distribute products as “stem cell therapy.” HCT/P 361 allografts are regulated under 21 CFR 1271 for homologous use and minimal manipulation. PRP is autologous. Marketing that blurs those lanes is a compliance problem in every state, including Wisconsin.
If you operate in Wisconsin and another MAC state, say it on the first call. J6 will not port 1:1. We would rather split utilization than watch a sister clinic copy Madison tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Madison, WI.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Madison is J6 geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Madison — 4.6 points below the U.S. 12% figure. Planning input, not an outcomes claim.
Wisconsin Part B wound biologics follow this contractor (siblings: IL, MN). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Madison. Useful for joint-program math; still needs a diagnosis and privileging.
No Madison storefront. Joe Bradley is an active practice owner. orthobiologic treatments stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.